The PRIME Curriculum Clinical research training during residency: Response to Kohlwes et al

por Gangat, Naseema
Publicado 2006

Venetoclax-based chemotherapy in acute and chronic myeloid neoplasms: literature survey and practice points

por Gangat, Naseema, Tefferi, Ayalew
Publicado en Blood Cancer J (2020)

An Electronic Search Algorithm for Early Disseminated Intravascular Coagulopathy Diagnosis in the Intensive Care Unit: A Derivation and Validation Study

por Jawaid, Tabinda, Gangat, Naseema, Weister, Timothy, Kashyap, Rahul
Publicado en Cureus (2020)

Is there a gender effect in polycythemia vera?

por Palandri, Francesca, Mora, Barbara, Gangat, Naseema, Catani, Lucia
Publicado en Ann Hematol (2020)

JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views

por Gangat, Naseema, Szuber, Natasha, Pardanani, Animesh, Tefferi, Ayalew
Publicado en Leukemia (2021)

Cyclic Bicytopenia in a Patient with Shapiro Syndrome

por Roeker, Lindsey E., Gupta, Vinay, Gonsalves, Wilson I., Wolanskyj, Alexandra P., Gangat, Naseema
Publicado 2013

Clonal evolution of AML on novel FMS-like tyrosine kinase-3 (FLT3) inhibitor therapy with evolving actionable targets

por Kasi, Pashtoon M., Litzow, Mark R., Patnaik, Mrinal M., Hashmi, Shahrukh K., Gangat, Naseema
Publicado en Leuk Res Rep (2016)

Validation of the WHO-defined 20% circulating blasts threshold for diagnosis of leukemic transformation in primary myelofibrosis

por Mudireddy, Mythri, Gangat, Naseema, Hanson, Curtis A., Ketterling, Rhett P., Pardanani, Animesh, Tefferi, Ayalew
Publicado en Blood Cancer J (2018)

Normal karyotype in myelofibrosis: is prognostic integrity affected by the number of metaphases analyzed?

por Nicolosi, Maura, Mudireddy, Mythri, Gangat, Naseema, Pardanani, Animesh, Hanson, Curtis A., Ketterling, Rhett P., Tefferi, Ayalew
Publicado en Blood Cancer J (2018)

Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: clinical and prognostic correlates

por Shah, Sahrish, Mudireddy, Mythri, Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema, Pardanani, Animesh, Tefferi, Ayalew
Publicado en Blood Cancer J (2017)

U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions

por Tefferi, Ayalew, Finke, Christy M., Lasho, Terra L., Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema, Pardanani, Animesh
Publicado en Leukemia (2018)

Secondary Hemophagocytic Syndrome Associated with Richter's Transformation in Chronic Lymphocytic Leukemia

por El-Haj, Nura, Gonsalves, Wilson I., Gupta, Vinay, Smeltzer, Jacob P., Parikh, Sameer A., Singh, Preet P., Gangat, Naseema
Publicado 2014

Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms

por Lasho, Terra L., Vallapureddy, Rangit, Finke, Christy M., Mangaonkar, Abhishek, Gangat, Naseema, Ketterling, Rhett, Tefferi, Ayalew, Patnaik, Mrinal M.
Publicado en Blood Cancer J (2018)

Sex and degree of severity influence the prognostic impact of anemia in primary myelofibrosis: analysis based on 1109 consecutive patients

por Nicolosi, Maura, Mudireddy, Mythri, Lasho, Terra L., Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema, Pardanani, Animesh, Tefferi, Ayalew
Publicado en Leukemia (2018)

Non Hepatosplenic Extramedullary Manifestations of Chronic Myelomonocytic Leukemia: Clinical, Molecular and Prognostic Correlates

por Hoversten, Kate, Vallapureddy, Rangit, Lasho, Terra, Finke, Christy, Ketterling, Rhett, Hanson, Curtis, Gangat, Naseema, Tefferi, Ayalew, Patnaik, Mrinal M.
Publicado en Leuk Lymphoma (2018)

MPL-mutated essential thrombocythemia: a morphologic reappraisal

por Szuber, Natasha, Hanson, Curtis A., Lasho, Terra L., Finke, Christy, Ketterling, Rhett P., Pardanani, Animesh, Gangat, Naseema, Tefferi, Ayalew
Publicado en Blood Cancer J (2018)

Targeted deep sequencing in primary myelofibrosis

por Tefferi, Ayalew, Lasho, Terra L., Finke, Christy M., Elala, Yoseph, Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema, Pardanani, Animesh
Publicado en Blood Adv (2016)

Nucleophosmin 1 (NPM1) Mutations in Chronic Myelomonocytic Leukemia and Their Prognostic Relevance

por Vallapureddy, Rangit, Lasho, Terra L., Hoversten, Katherine, Finke, Christy M., Ketterling, Rhett, Hanson, Curtis, Gangat, Naseema, Tefferi, Ayalew, Patnaik, Mrinal M.
Publicado en Am J Hematol (2017)

EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental

por Patnaik, Mrinal M., Vallapureddy, Rangit, Lasho, Terra L., Hoversten, Katherine P., Finke, Christy M., Ketterling, Rhett, Hanson, Curtis, Gangat, Naseema, Tefferi, Ayalew
Publicado en Blood Cancer J (2018)

Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients

por Tefferi, Ayalew, Nicolosi, Maura, Mudireddy, Mythri, Lasho, Terra L., Gangat, Naseema, Begna, Kebede H., Hanson, Curtis A., Ketterling, Rhett P., Pardanani, Animesh
Publicado en Leukemia (2018)